Lauri Burroughs is an Oncology physician affiliated with Fred Hutch Cancer Center. OpenAlex indexes 111 publications with 4,374 citations (h-index 30); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4800 Sand Point Way NE
Seattle, WA 981053901
Telephone
206-987-2106Registry record last updated 28 Dec 2011.
Clinical trials
- Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Sponsor: Fred Hutchinson Cancer Center
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
Sponsor: Fred Hutchinson Cancer Center
- Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year20231 payment
- Horizon Therapeutics plcProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2007–2010 per NIH RePORTER. The latest:
- Nonmyeloablative Allografting for Immunodeficiency & Other Nonmalignant Disorders
Fred Hutchinson Cancer Research Center
FY2010$136,485K23HL085288 - Nonmyeloablative Allografting for Immunodeficiency & Other Nonmalignant Disorders
Fred Hutchinson Cancer Research Center
FY2009$136,485K23HL085288 - Nonmyeloablative Allografting for Immunodeficiency & Other Nonmalignant Disorders
Fred Hutchinson Cancer Research Center
FY2008$136,485K23HL085288
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Riddell, MD
Fred Hutch Cancer Center
Sunil Hingorani, MD, PhD
Fred Hutch Cancer Center
Paul Nghiem
Fred Hutch Cancer Center
Soheil Meshinchi, MD, PhD
Fred Hutch Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”